Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Defining Melanoma Immune Biomarkers-Desert, Excluded, and Inflamed Subtypes-Using a Gene Expression Classifier Reflecting Intratumoral Immune Response and Stromal Patterns.

  • Authors : Mlynska A; National Cancer Institute, LT-08406 Vilnius, Lithuania.; Faculty of Fundamental Sciences, Vilnius Gediminas Technical University, LT-10223 Vilnius, Lithuania.

Subjects: Melanoma*/Melanoma*/Melanoma*/pathology; Humans ; Biomarkers/Biomarkers/Biomarkers/metabolism

  • Source: Biomolecules [Biomolecules] 2024 Jan 31; Vol. 14 (2). Date of Electronic Publication: 2024 Jan 31.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium: Internet ISSN: 2218-273X

Record details

×
Academic Journal

Promising and Minimally Invasive Biomarkers: Targeting Melanoma.

  • Authors : Spiliopoulou P; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C1, Canada.; School of Cancer Sciences, University of Glasgow, Glasgow G61 1BD, UK.

Subjects: Melanoma*/Melanoma*/Melanoma*/genetics ; Skin Neoplasms*/Skin Neoplasms*/Skin Neoplasms*/diagnosis ; Skin Neoplasms*/Skin Neoplasms*/Skin Neoplasms*/genetics

  • Source: Cells [Cells] 2023 Dec 20; Vol. 13 (1). Date of Electronic Publication: 2023 Dec 20.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

Record details

×
Academic Journal

Pre-treatment 18F-FDG-PET/CT parameters as biomarkers for progression free survival, best overall response and overall survival in metastatic melanoma patients undergoing first-line immunotherapy.

  • Authors : Peisen F; Department of Diagnostic and Interventional Radiology, Eberhard Karls University, Tuebingen University Hospital, Tuebingen, Germany.; Gerken A

Subjects: Melanoma*/Melanoma*/Melanoma*/diagnostic imaging ; Melanoma*/Melanoma*/Melanoma*/drug therapy ; Neoplasms, Second Primary*

  • Source: PloS one [PLoS One] 2024 Jan 05; Vol. 19 (1), pp. e0296253. Date of Electronic Publication: 2024 Jan 05 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Identification and validation of a costimulatory molecule-related signature to predict the prognosis for uveal melanoma patients.

  • Authors : Zhao M; Department of Ophthalmology, Shanghai Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.; Yu Y

Subjects: Uveal Neoplasms*/Uveal Neoplasms*/Uveal Neoplasms*/genetics ; Uveal Neoplasms*/Uveal Neoplasms*/Uveal Neoplasms*/mortality ; Uveal Neoplasms*/Uveal Neoplasms*/Uveal Neoplasms*/immunology Uveal melanoma

  • Source: Scientific reports [Sci Rep] 2024 Apr 21; Vol. 14 (1), pp. 9146. Date of Electronic Publication: 2024 Apr 21.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

H-VISTA Immunohistochemistry Score Is Associated with Advanced Stages in Cutaneous and Ocular Melanoma.

  • Authors : Tinca AC; Doctoral School of Medicine and Pharmacy, University of Medicine, Pharmacy, Sciences and Technology 'George Emil Palade' of Targu Mures, 540142 Targu Mures, Romania.; Pathology Department, Mures Clinical County Hospital, 540011 Targu Mures, Romania.

Subjects: Melanoma*/Melanoma*/Melanoma*/metabolism ; Melanoma*/Melanoma*/Melanoma*/pathology ; Melanoma*/Melanoma*/Melanoma*/diagnosis

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Apr 14; Vol. 25 (8). Date of Electronic Publication: 2024 Apr 14.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.

  • Authors : Leek LVM; Department of Medical Oncology, Netherlands Cancer Institute, Antoni Van Leeuwenhoek, Amsterdam, The Netherlands.; Notohardjo JCL

Subjects: Melanoma*/Melanoma*/Melanoma*/drug therapy ; Melanoma*/Melanoma*/Melanoma*/pathology ; Melanoma*/Melanoma*/Melanoma*/metabolism

  • Source: Scientific reports [Sci Rep] 2024 May 16; Vol. 14 (1), pp. 11244. Date of Electronic Publication: 2024 May 16.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Cutaneous Melanoma: A Review of Multifactorial Pathogenesis, Immunohistochemistry, and Emerging Biomarkers for Early Detection and Management.

  • Authors : Gosman LM; Doctoral School, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.; Department of Pathology, Saint Pantelimon Clinical Emergency Hospital, 021659 Bucharest, Romania.

Subjects: Melanoma*/Melanoma*/Melanoma*/diagnosis ; Melanoma*/Melanoma*/Melanoma*/etiology ; Melanoma*/Melanoma*/Melanoma*/therapy

  • Source: International journal of molecular sciences [Int J Mol Sci] 2023 Nov 01; Vol. 24 (21). Date of Electronic Publication: 2023 Nov 01.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma.

  • Authors : Serratì S; IRCCS Istituto Tumori Giovanni Paolo II, V.Le O. Flacco, 65, 70124, Bari, Italy.; Di Fonte R

Subjects: Melanoma*/Melanoma*/Melanoma*/drug therapy ; Extracellular Vesicles*; Humans

  • Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Sep 28; Vol. 42 (1), pp. 251. Date of Electronic Publication: 2023 Sep 28.Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966

Record details

×
Academic Journal

Gene signature from cutaneous autoimmune diseases provides potential immunotherapy-relevant biomarkers in melanoma.

  • Authors : Chun KH; Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, 03722, Korea.; Department of Biochemistry and Molecular Biology, Yonsei University College of Medicine, Seoul, 03722, Korea.

Subjects: Melanoma*/Melanoma*/Melanoma*/genetics ; Melanoma*/Melanoma*/Melanoma*/therapy ; Skin Diseases*

  • Source: Scientific reports [Sci Rep] 2023 Sep 12; Vol. 13 (1), pp. 15023. Date of Electronic Publication: 2023 Sep 12.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Identification of Plasma Lipid Alterations Associated with Melanoma Metastasis.

  • Authors : Szász I; HUN-REN-UD Public Health Research Group, Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, 4028 Debrecen, Hungary.; Koroknai V

Subjects: Melanoma*/Melanoma*/Melanoma*/blood ; Melanoma*/Melanoma*/Melanoma*/pathology ; Lipids*/Lipids*/Lipids*/blood

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Apr 11; Vol. 25 (8). Date of Electronic Publication: 2024 Apr 11.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
  • 1-10 of  1,132 results for ""Biomarkers""